drugset / Trial / NCT02833610
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
Phase 2
Completed
55 enrolled
Massachusetts General Hospital
Amgen · collabEmory University · collabUniversity Hospitals Cleveland Medical Center · collabUniversity of Rochester · collab
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying a possible therapy as a possible treatment for the consequences of Multiple Myeloma with renal insufficiency.
Timeline
- Start
- 2016-08
- Primary completion
- 2023-03-20
- Completion
- 2023-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denosumab | Monoclonal antibody | — | Subcutaneous |